We present high-energy x-ray diffraction studies on the structural phases of an optimal high-T c superconductor La 2−x Sr x CuO 4+y tailored by co-hole-doping. This is specifically done by varying the content of two very different chemical species, Sr and O, respectively, in order to study the influence of each. A superstructure known as staging is observed in all samples, with the staging number n increasing for higher Sr dopings x. We find that the staging phases emerge abruptly with temperature, and can be described as a second-order phase transition with transition temperatures slightly depending on the Sr doping. The Sr appears to correlate the interstitial oxygen in a way that stabilizes the reproducibility of the staging phase both in terms of staging period and volume fraction in a specific sample. The structural details as investigated in this paper appear to have no direct bearing on the electronic phase separation previously observed in the same samples. This provides evidence that the electronic phase separation is determined by the overall hole concentration rather than specific Sr/O content and concomitant structural details.
Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.